Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLC
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Northeast Alabama Medical Center
Anniston, Alabama, United States
- Northeast Arkansas Clinic
Jonesboro, Arkansas, United States
- Florida Cancer Specialists
Fort Myers, Florida, United States
- Gulfcoast Oncology Associates
St. Petersburg, Florida, United States
- Medical Oncology Associates of Augusta
Augusta, Georgia, United States
- Northeast Georgia Medical Center
Gainesville, Georgia, United States
- Wellstar Cancer Research
Marietta, Georgia, United States
- Providence Medical Group
Terre Haute, Indiana, United States
- Rhhp/hope Cancer Center
Terre Haute, Indiana, United States
- Baptist Hospital East
Louisville, Kentucky, United States
- Norton Cancer Institute
Louisville, Kentucky, United States
- Hematology Oncology Life Center
Alexandria, Louisiana, United States
- Hematology Oncology Clinic, Llp
Baton Rouge, Louisiana, United States
- Center for Cancer and Blood Disorders
Bethesda, Maryland, United States
- Jackson Oncology Associates
Jackson, Mississippi, United States
- St. Louis Cancer Care
Chesterfield, Missouri, United States
- Nebraska Methodist Cancer Center
Omaha, Nebraska, United States
- Portsmouth Regional Hospital
Portsmouth, New Hampshire, United States
- Hematology Oncology Associates of Northern Nj
Morristown, New Jersey, United States
- New Mexico Oncology Hematology Consultants
Albuquerque, New Mexico, United States
- Cancer Care of Western North Carolina
Asheville, North Carolina, United States
- Oncology Hematology Care
Cincinnati, Ohio, United States
- Associates in Hematology Oncology
Chattanooga, Tennessee, United States
- Chattanooga Oncology Hematology Associates
Chattanooga, Tennessee, United States
- Tennessee Oncology, Pllc
Nashville, Tennessee, United States
- Peninsula Cancer Institute
Newport News, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2007
- Primary completion
- 31 Jul 2013
- Completion
- 28 Feb 2014
- Last update posted
- 8 Jun 2015
- Registered enrollment
- 112
- Registry id
- NCT00621049
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.